China Orders Last Indian Journalist in Country to Leave
The last Indian journalist in China has been asked to leave, as Beijing and New Delhi eject each
1970-01-01 08:00
Nomura to Scale Back Loss-Making Brokerage Venture With Line
Nomura Holdings Inc. plans to scale back a brokerage venture with messaging app operator Line Group amid a
1970-01-01 08:00
Sam Bankman-Fried’s Risky Japan Trade Seeded a Crypto Empire
Fresh out of college, Sam Bankman-Fried had a trading job at Jane Street Group in New York. As
1970-01-01 08:00
Rio Tinto, China Baowu to Jointly Explore Green Steel Projects
The world’s biggest iron ore miner and top steel producer are teaming up to collaborate on projects to
1970-01-01 08:00
Novartis Agrees to Buy Chinook for Up to $3.5 Billion
Novartis AG agreed to buy Chinook Therapeutics Inc. for as much as $3.5 billion to add two promising
1970-01-01 08:00
Goldman Sachs Raises S&P 500 View Saying Rally to Broaden Beyond Tech
The rally in US equities will broaden beyond megacap technology names if history is any guide, Goldman Sachs
1970-01-01 08:00
UBS Completes Credit Suisse Takeover to Create Swiss Bank Titan
UBS Group AG completed the deal to acquire former rival Credit Suisse Group AG, sealing the biggest merger
1970-01-01 08:00
UBS to Impose Risk Limits on CS With Deal Set to Close, FT Says
UBS Group AG will impose strict restrictions on bankers from Credit Suisse Group AG, including a ban on
1970-01-01 08:00
US Economy Remains ‘Very, Very Hot,’ Larry Summers Says
The US economy remains “very, very hot,” though not as much as it was six to 12 months
1970-01-01 08:00
Microsoft Gaming Chief Doesn’t See a Need for New Xbox Yet
Microsoft Corp.’s video gaming chief Phil Spencer said he doesn’t “feel an imperative” to come out with a
1970-01-01 08:00
Goldman Expects ‘L-Shaped’ Recovery in China’s Property Market
China’s struggling real estate industry is expected to see an L-shaped recovery in the coming years, placing a
1970-01-01 08:00
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the
1970-01-01 08:00